IBN SINA recommends 60% cash dividend for FY23

Its consolidated net asset value per share stood at Tk96.68 at the end of June 2023

The IBN SINA Pharmaceutical Industry PLC has declared a record 60% cash dividend to its shareholders for the financial year 2022-23.  

The dividend declaration came from the company’s board meeting on Monday (28 August).

During the year, the consolidated earnings per share of the pharmaceutical stood at Tk19.38, which was Tk19.39 in FY2021 -22.

Its consolidated net asset value per share stood at Tk96.68 at the end of June 2023.

To approve the dividend and financial statement, it will conduct the annual general meeting on 22 October virtually, and the record date is set for 21 September.

Its share stood at Tk286.60 apiece on Tuesday at the Dhaka Stock Exchange.

Source: The Business Standard

Shopping Basket

Capital Market Risk Assessment Survey

Iram Hoque

Mohd. Iramul Hoque (Iram) completed his bachelor’s degree in Industrial Engineering in 2018 from Purdue University.

He joined Deloitte Consulting LLP as a Consulting Analyst based out of New York City having previously worked in similar roles at PricewaterhouseCoopers LLP & Landis+Gyr.

Iram left consulting and returned to Bangladesh to take up the family business. Realizing the opportunity in the capital market in Bangladesh, Iram worked relentlessly to found Columbia Shares & Securities Ltd in 2021.

Md Saiful Hoque

Md. Saiful Hoque received his bachelor’s degree in Civil Engineering from Columbia University in 1986 followed by a master’s degree from Texas A&M University in 1988. Upon completion of his Graduate Degree, he joined Gulf Interstate Engineering Company in Houston, USA serving as a Project Engineer.

He returned to Bangladesh in 1992 to join Columbia Enterprise Ltd., the family business of Shipping and Freight Forwarding services. In addition, he has built flourishing businesses manufacturing Garment’s Accessories and Fast-Moving Consumer Goods.